Company intelligence / Profile preview

InnoVoyce

Boston, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

The VYLO™ Laser System is FDA-cleared for a broad spectrum of soft tissue surgical procedures, delivering surgical precision with up to 30W power and four emission modes. Early clinical adoption highlights its efficacy, control, and safety, especially for delicate ENT and laryngeal surgeries

Therapeutic areas: OphthalmologyWomen's HealthGastroenterologyNeurologyOtherMen's Health
Modalities: Device (Laser system)
Industry: Surgical Medical Devices

Partnerships

Voice Health InstituteCollaboration with Harvard Medical experts

Beyond the preview

Go deeper on InnoVoyce.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoVoyce.

Explore the full profile